CN1399626A - 甲基文拉法辛的醚 - Google Patents
甲基文拉法辛的醚 Download PDFInfo
- Publication number
- CN1399626A CN1399626A CN00816149A CN00816149A CN1399626A CN 1399626 A CN1399626 A CN 1399626A CN 00816149 A CN00816149 A CN 00816149A CN 00816149 A CN00816149 A CN 00816149A CN 1399626 A CN1399626 A CN 1399626A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- alkyl
- group
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Abstract
Description
Claims (16)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44826899A | 1999-11-24 | 1999-11-24 | |
US09/448,268 | 1999-11-24 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2004100882450A Division CN1636559A (zh) | 1999-11-24 | 2000-11-21 | 甲基文拉法辛的醚 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1399626A true CN1399626A (zh) | 2003-02-26 |
CN1198793C CN1198793C (zh) | 2005-04-27 |
Family
ID=23779642
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008161496A Expired - Fee Related CN1198793C (zh) | 1999-11-24 | 2000-11-21 | 甲基文拉法辛的醚 |
CNA2004100882450A Pending CN1636559A (zh) | 1999-11-24 | 2000-11-21 | 甲基文拉法辛的醚 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2004100882450A Pending CN1636559A (zh) | 1999-11-24 | 2000-11-21 | 甲基文拉法辛的醚 |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1232141B1 (zh) |
JP (1) | JP2003514889A (zh) |
KR (1) | KR100843991B1 (zh) |
CN (2) | CN1198793C (zh) |
AR (1) | AR024498A1 (zh) |
AT (1) | ATE278659T1 (zh) |
AU (1) | AU767835B2 (zh) |
BR (1) | BR0015795A (zh) |
CA (1) | CA2391288A1 (zh) |
CZ (1) | CZ20021816A3 (zh) |
DE (1) | DE60014693T2 (zh) |
DK (1) | DK1232141T3 (zh) |
ES (1) | ES2228636T3 (zh) |
HK (1) | HK1045835A1 (zh) |
HU (1) | HUP0203594A2 (zh) |
IL (2) | IL149531A0 (zh) |
MX (1) | MXPA02005174A (zh) |
NO (1) | NO20022446D0 (zh) |
NZ (1) | NZ519130A (zh) |
PL (1) | PL202846B1 (zh) |
PT (1) | PT1232141E (zh) |
SI (1) | SI1232141T1 (zh) |
TW (1) | TWI268919B (zh) |
WO (1) | WO2001038293A1 (zh) |
ZA (1) | ZA200204986B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103319373A (zh) * | 2012-03-23 | 2013-09-25 | 浙江九洲药业股份有限公司 | 1-[2-氨基-1-(4-苄氧基苯基)乙基]环己烷醇的制备方法及相关中间体 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
KR101477154B1 (ko) * | 2010-10-01 | 2014-12-29 | 산동 루예 파마슈티칼 컴파니 리미티드 | 4-[2-디메틸아미노-1-(1-하이드록시사이클로헥실)에틸]페닐 4-메틸벤조에이트 하이드로클로라이드의 다형체, 이의 제조 방법 및 이의 용도 |
-
2000
- 2000-11-21 PT PT00980588T patent/PT1232141E/pt unknown
- 2000-11-21 PL PL355171A patent/PL202846B1/pl not_active IP Right Cessation
- 2000-11-21 SI SI200030509T patent/SI1232141T1/xx unknown
- 2000-11-21 HU HU0203594A patent/HUP0203594A2/hu unknown
- 2000-11-21 CN CNB008161496A patent/CN1198793C/zh not_active Expired - Fee Related
- 2000-11-21 EP EP00980588A patent/EP1232141B1/en not_active Expired - Lifetime
- 2000-11-21 JP JP2001539850A patent/JP2003514889A/ja not_active Withdrawn
- 2000-11-21 KR KR1020027006602A patent/KR100843991B1/ko not_active IP Right Cessation
- 2000-11-21 CN CNA2004100882450A patent/CN1636559A/zh active Pending
- 2000-11-21 CZ CZ20021816A patent/CZ20021816A3/cs unknown
- 2000-11-21 NZ NZ519130A patent/NZ519130A/en unknown
- 2000-11-21 BR BR0015795-3A patent/BR0015795A/pt active Pending
- 2000-11-21 CA CA002391288A patent/CA2391288A1/en not_active Abandoned
- 2000-11-21 ES ES00980588T patent/ES2228636T3/es not_active Expired - Lifetime
- 2000-11-21 WO PCT/US2000/031895 patent/WO2001038293A1/en active IP Right Grant
- 2000-11-21 IL IL14953100A patent/IL149531A0/xx unknown
- 2000-11-21 DE DE60014693T patent/DE60014693T2/de not_active Expired - Fee Related
- 2000-11-21 MX MXPA02005174A patent/MXPA02005174A/es active IP Right Grant
- 2000-11-21 DK DK00980588T patent/DK1232141T3/da active
- 2000-11-21 AT AT00980588T patent/ATE278659T1/de not_active IP Right Cessation
- 2000-11-21 AU AU17833/01A patent/AU767835B2/en not_active Ceased
- 2000-11-22 AR ARP000106165A patent/AR024498A1/es unknown
- 2000-11-23 TW TW089124917A patent/TWI268919B/zh not_active IP Right Cessation
-
2002
- 2002-05-08 IL IL149531A patent/IL149531A/en not_active IP Right Cessation
- 2002-05-23 NO NO20022446A patent/NO20022446D0/no not_active Application Discontinuation
- 2002-06-20 ZA ZA200204986A patent/ZA200204986B/en unknown
- 2002-10-09 HK HK02107379A patent/HK1045835A1/xx not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103319373A (zh) * | 2012-03-23 | 2013-09-25 | 浙江九洲药业股份有限公司 | 1-[2-氨基-1-(4-苄氧基苯基)乙基]环己烷醇的制备方法及相关中间体 |
Also Published As
Publication number | Publication date |
---|---|
IL149531A0 (en) | 2002-11-10 |
MXPA02005174A (es) | 2002-11-07 |
EP1232141B1 (en) | 2004-10-06 |
NO20022446L (no) | 2002-05-23 |
BR0015795A (pt) | 2002-07-23 |
AU1783301A (en) | 2001-06-04 |
WO2001038293A1 (en) | 2001-05-31 |
JP2003514889A (ja) | 2003-04-22 |
TWI268919B (en) | 2006-12-21 |
ES2228636T3 (es) | 2005-04-16 |
CN1198793C (zh) | 2005-04-27 |
KR20030058931A (ko) | 2003-07-07 |
HK1045835A1 (en) | 2002-12-13 |
KR100843991B1 (ko) | 2008-07-07 |
NZ519130A (en) | 2003-09-26 |
PL202846B1 (pl) | 2009-07-31 |
IL149531A (en) | 2008-12-29 |
PT1232141E (pt) | 2004-12-31 |
EP1232141A1 (en) | 2002-08-21 |
ATE278659T1 (de) | 2004-10-15 |
DK1232141T3 (da) | 2004-11-29 |
SI1232141T1 (en) | 2004-12-31 |
ZA200204986B (en) | 2003-09-27 |
NO20022446D0 (no) | 2002-05-23 |
CN1636559A (zh) | 2005-07-13 |
AU767835B2 (en) | 2003-11-27 |
CZ20021816A3 (cs) | 2002-08-14 |
CA2391288A1 (en) | 2001-05-31 |
DE60014693D1 (en) | 2004-11-11 |
DE60014693T2 (de) | 2005-03-10 |
PL355171A1 (en) | 2004-04-05 |
HUP0203594A2 (en) | 2003-02-28 |
AR024498A1 (es) | 2002-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1028103C (zh) | 哌啶基苯并咪唑类化合物的制备方法 | |
RU2397163C2 (ru) | Способ получения производных бензопиран-2-ола | |
EA004770B1 (ru) | Новые сложные эфиры, производные (rr, ss)-3-(2-диметиламинометил -1-гидроксициклогексил)фенил 2-гидроксибензоата | |
CN1163884A (zh) | 作为药物有效成分的二甲基-(3-芳基-丁-3-烯基)-胺化合物 | |
US6348494B1 (en) | Ethers of o-desmethyl venlafaxine | |
EP0711272A1 (en) | Indane and tetrahydronaphthalene derivatives as calcium channel antagonists | |
CN1113856C (zh) | 新的[(3-烷氧基苯氧基)乙基]二烷基胺衍生物及其作为局部麻醉剂的应用 | |
CN1198793C (zh) | 甲基文拉法辛的醚 | |
CN1085217A (zh) | 1,4-苯并二噁烷衍生物 | |
CN1437576A (zh) | 取代的氨甲基-苯基-环己烷衍生物 | |
CN1127250A (zh) | 2,3-桥连的1,4-二氢吡啶类化合物及其制法和其药用 | |
US7291646B2 (en) | Ethers of O-desmethyl venlafaxine | |
CN1188405C (zh) | 新的吗啉代苯甲酰胺盐 | |
CN1903833A (zh) | 一种制备托特罗定及其l-酒石酸盐的方法 | |
CN1107469A (zh) | 环胺衍生物 | |
CN1622944A (zh) | 生产2-[5-(4-氟苯基)-3-吡啶基甲氨基甲基]苯并二氢吡喃的方法 | |
CN109824605B (zh) | 瑞舒伐他汀钙的合成方法 | |
CN109836386B (zh) | 瑞舒伐他汀钙的合成工艺 | |
JP2009019004A (ja) | 光学活性アリールオキシカルボン酸誘導体の製造方法 | |
WO2004094436A1 (en) | 1-(2-amino-1-phenyl-ethyl) 1- silacyclohexan-1- ol derivatives and use thereof in the preparation of a medicament | |
EP1220833A1 (en) | Process and intermediates for making 4-cyanosubstituted cyclohexanoic acids | |
CN1416417A (zh) | 制备环己腈的方法和中间体 | |
TW201109329A (en) | Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CI01 | Publication of corrected invention patent application |
Correction item: Inventor Correct: Ullrich John William False: Missing third inventor Number: 9 Volume: 19 |
|
CI02 | Correction of invention patent application |
Correction item: Inventor Correct: Ullrich John William False: Missing third inventor Number: 9 Page: The title page Volume: 19 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: MISS OF 3RD INVENTOR TO: ULLRICH JOHN WILLIAM |
|
ERR | Gazette correction |
Free format text: CORRECT: INVENTOR; FROM: MISS OF 3RD INVENTOR TO: ULLRICH JOHN WILLIAM |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050427 Termination date: 20091221 |